findmyKOL
Clinical trialNCT02649894CompletedInterventional

Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter

SponsorC. R. BardEnrollment119Malignant Pleural Effusion
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Southmead Hospital

    Bristol, United Kingdom

  • Oxford Center for Respiratory Medicine, Churchill Hospital

    Oxford, United Kingdom

  • Great Western Hospital

    Swindon, United Kingdom

United States
  • Heart Center Research

    Huntsville, Alabama, United States

  • Stanford University School of Medicine/ Stanford Cancer Institute

    Stanford, California, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Northwestern Unversity

    Chicago, Illinois, United States

  • St. Vincent Medical Group

    Indianapolis, Indiana, United States

  • Johns Hopkins Hospital

    Baltimore, Maryland, United States

  • Beth Israel Deconess Medical Center West

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Washington Universtiy School of Medicine, Barnes Jewish Hospital

    St Louis, Missouri, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Suny Upstate Hospital

    Syracuse, New York, United States

  • Unc Hospital

    Chapel Hill, North Carolina, United States

  • Duke University

    Durham, North Carolina, United States

  • Vanderbuilt University

    Nashville, Tennessee, United States

  • University of Texas, Md Anderson Cancer Center

    Houston, Texas, United States

  • Huntsman Cancer Institute

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2016
Primary completion
18 Apr 2018
Completion
18 Apr 2018
Last update posted
11 Dec 2025
Registered enrollment
119
Registry id
NCT02649894

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.